Investor
Bronte Capital Management Pty Ltd.
CIK 0001471085 · filed 2026-04-27 · SEC filing
13F book
$1.01B
Positions
51
9 new · 1 sold
Largest name
13.2%
Regeneron Pharmaceuticals, Inc. · REGN
Est. mark
−$37.7M
Price effect on 42 names still held. Flow $21.8M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | REGN | 172.8K | $133.5M | 13.2% | $133K | Cut−$2.94M |
| Alphabet Inc | — | 381.5K | $109.7M | 10.9% | −$9.71M | Cut−$20.5M |
| Interactive Brokers Group In | — | 1.28M | $86M | 8.5% | $3.54M | Cut−$9.62M |
| Berkshire Hathaway Inc Del | — | 155.1K | $74.3M | 7.4% | −$3.64M | Cut−$7.29M |
| Visa Inc-Class A Shares | — | 239.4K | $72.3M | 7.2% | −$11.4M | Added−$10.1M |
| Amazon Com Inc | AMZN | 285.7K | $59.5M | 5.9% | −$6.26M | Added−$4.57M |
| Philip Morris Intl Inc | — | 341.1K | $56.4M | 5.6% | $1.69M | Cut−$7.53M |
| Corteva, Inc. | CTVA | 502.8K | $42.1M | 4.2% | $8.39M | Cut$3.95M |
| Capital One Finl Corp | — | 187.4K | $34.2M | 3.4% | −$10.5M | Added−$8.36M |
| First Ctzns Bancshares Inc D | — | 16.5K | $31.1M | 3.1% | −$4.31M | Cut−$5.56M |
| Vaneck Etf Trust | — | 208.1K | $19.1M | 1.9% | $1.25M | Cut$427.8K |
| Disney Walt Co | — | 185.7K | $17.9M | 1.8% | — | New |
| Bbb Foods Inc | TBBB | 487.6K | $17.2M | 1.7% | $780.4K | Added$4.08M |
| Nektar Therapeutics | NKTR | 198.3K | $14.3M | 1.4% | — | New |
| Herbalife Ltd. | HLF | 939.9K | $13.8M | 1.4% | $1.72M | Cut−$603.3K |
| Graham Hldgs Co | — | 12.8K | $13.5M | 1.3% | −$528.5K | Cut−$1.15M |
| Brown Forman Corp | — | 493.9K | $13.1M | 1.3% | — | New |
| Alnylam Pharmaceuticals, Inc. | ALNY | 37.2K | $12.3M | 1.2% | −$2.49M | Cut−$3.13M |
| Sotera Health Co | SHC | 843.7K | $12.1M | 1.2% | −$2.78M | Cut−$3.33M |
| Ishares Tr | — | 37.5K | $11.8M | 1.2% | — | New |
| Ishares Tr | — | 69.3K | $11.7M | 1.2% | $5.54K | Cut−$515.1K |
| Sociedad Quimica Y Minera De | — | 122.4K | $9.91M | 1.0% | $1.49M | Cut−$1.34M |
| Aurora Innovation Inc | — | 2.32M | $9.55M | 0.9% | — | New |
| Newmont Corp | — | 75.4K | $8.16M | 0.8% | $633.4K | Cut$389K |
| Pinterest, Inc. | PINS | 430.9K | $7.9M | 0.8% | −$3.25M | Cut−$5.36M |
| Global-E Online Ltd. | GLBE | 213.1K | $6.57M | 0.7% | — | New |
| Barrick Mng Corp | — | 158.7K | $6.48M | 0.6% | −$438.1K | Cut−$704.4K |
| Liveramp Hldgs Inc | — | 223.2K | $5.92M | 0.6% | −$636.2K | Cut−$894K |
| Paylocity Hldg Corp | — | 36.6K | $3.96M | 0.4% | — | New |
| Turning Pt Brands Inc | — | 42.9K | $3.72M | 0.4% | −$526.7K | Added$1.08M |
| Mondelez Intl Inc | — | 56K | $3.23M | 0.3% | $213.3K | Cut−$248.2K |
| Vaneck Etf Trust | — | 26.6K | $3.19M | 0.3% | $166.3K | Cut$30.1K |
| Sally Beauty Hldgs Inc | — | 220.7K | $3.06M | 0.3% | −$90.5K | Cut−$7.46M |
| Bath & Body Works, Inc. | BBWI | 155.5K | $2.9M | 0.3% | −$219.3K | Cut−$2.21M |
| Brown Forman Corp | — | 100.4K | $2.69M | 0.3% | — | New |
| James Riv Group Holdings Inc | — | 339K | $2.14M | 0.2% | −$7.41K | Added$1.35M |
| Riskified Ltd. | RSKD | 488.5K | $1.91M | 0.2% | −$512.9K | Cut−$638.1K |
| Nice Ltd | — | 17.1K | $1.88M | 0.2% | −$47.5K | Cut−$412.7K |
| Universal Display Corp | — | 11.1K | $1.02M | 0.1% | −$279.4K | Cut−$341.5K |
| Verisk Analytics, Inc. | VRSK | 2.9K | $550.7K | 0.1% | — | New |
| Enovix Corp | ENVX | 11.6K | $59.8K | 0.0% | −$24.6K | Held |
| Alector, Inc. | ALEC | 19.3K | $41.5K | 0.0% | $11.4K | Held |
| Coherus Oncology, Inc. | CHRS | 19.3K | $32.6K | 0.0% | $5.21K | Held |
| Caribou Biosciences, Inc. | CRBU | 15.6K | $29.7K | 0.0% | $4.84K | Held |
| Fate Therapeutics Inc | FATE | 22.9K | $27.4K | 0.0% | $4.97K | Held |
| C4 Therapeutics, Inc. | CCCC | 10K | $26.4K | 0.0% | $7.22K | Held |
| Pliant Therapeutics, Inc. | PLRX | 18.6K | $23.5K | 0.0% | $744 | Held |
| Invivyd, Inc. | IVVD | 11K | $14.3K | 0.0% | −$12.9K | Held |
| Milestone Pharmaceuticals In | — | 10.4K | $12.4K | 0.0% | −$8.64K | Held |
| Rani Therapeutics Hldgs Inc | — | 14.9K | $10.9K | 0.0% | −$9.15K | Held |
| Fractyl Health, Inc. | GUTS | 16.9K | $7.74K | 0.0% | −$29.5K | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.